Deutsche Bank’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-375
| Closed | -$10.8K | – | 3649 |
|
|
2024
Q3 | $10.8K | Buy |
375
+3
| +0.8% | +$82 | ﹤0.01% | 3504 |
|
|
2024
Q2 | $9.22K | Buy |
372
+61
| +20% | +$1.73K | ﹤0.01% | 3465 |
|
|
2024
Q1 | $10K | Sell |
311
-3,784
| -92% | -$141K | ﹤0.01% | 3533 |
|
|
2023
Q4 | $166K | Buy |
+4,095
| New | +$151K | ﹤0.01% | 2973 |
|
|
2023
Q3 | – | Sell |
-294,207
| Closed | -$12M | – | 3749 |
|
|
2023
Q2 | $12M | Hold |
294,207
| – | – | 0.01% | 921 |
|
|
2023
Q1 | $11.4M | Hold |
294,207
| – | – | 0.01% | 930 |
|
|
2022
Q4 | $13.1M | Hold |
294,207
| – | – | 0.01% | 876 |
|
|
2022
Q3 | $12.5M | Hold |
294,207
| – | – | 0.01% | 886 |
|
|
2022
Q2 | $16.4M | Hold |
294,207
| – | – | 0.01% | 834 |
|
|
2022
Q1 | $18.2M | Buy |
+294,207
| New | +$18M | 0.01% | 862 |
|
|
2021
Q3 | – | Sell |
-1,040
| Closed | -$72K | – | 4504 |
|
|
2021
Q2 | $72K | Sell |
1,040
-6,575
| -86% | -$501K | ﹤0.01% | 4233 |
|
|
2021
Q1 | $587K | Sell |
7,615
-8,298
| -52% | -$764K | ﹤0.01% | 3003 |
|
|
2020
Q4 | $1.58M | Buy |
15,913
+9,636
| +154% | +$1.18M | ﹤0.01% | 2099 |
|
|
2020
Q3 | $891K | Buy |
6,277
+3,505
| +126% | +$584K | ﹤0.01% | 2273 |
|
|
2020
Q2 | $547K | Buy |
2,772
+867
| +46% | +$180K | ﹤0.01% | 2576 |
|
|
2020
Q1 | $373K | Sell |
1,905
-308
| -14% | -$66.3K | ﹤0.01% | 2625 |
|
|
2019
Q4 | $457K | Sell |
2,213
-15,644
| -88% | -$2.89M | ﹤0.01% | 2770 |
|
|
2019
Q3 | $2.72M | Sell |
17,857
-14,388
| -45% | -$2.36M | ﹤0.01% | 1733 |
|
|
2019
Q2 | $4.16M | Sell |
32,245
-10,696
| -25% | -$1.27M | ﹤0.01% | 1929 |
|
|
2019
Q1 | $5.06M | Buy |
42,941
+41,441
| +2,763% | +$4.18M | ﹤0.01% | 1867 |
|
|
2018
Q4 | $137K | Sell |
1,500
-16,699
| -92% | -$1.69M | ﹤0.01% | 4065 |
|
|
2018
Q3 | $2.05M | Sell |
18,199
-27,124
| -60% | -$2.87M | ﹤0.01% | 2840 |
|
|
2018
Q2 | $4.18M | Sell |
45,323
-37,827
| -45% | -$3.67M | ﹤0.01% | 2430 |
|
|
2018
Q1 | $8.29M | Buy |
83,150
+11,030
| +15% | +$1.19M | ﹤0.01% | 1780 |
|
|
2017
Q4 | $6.76M | Sell |
72,120
-6,502
| -8% | -$615K | ﹤0.01% | 1780 |
|
|
2017
Q3 | $8M | Sell |
78,622
-90,773
| -54% | -$7.93M | 0.01% | 1608 |
|
|
2017
Q2 | $13M | Buy |
169,395
+105,855
| +167% | +$8.9M | 0.01% | 1210 |
|
|
2017
Q1 | $5.47M | Buy |
63,540
+24,716
| +64% | +$1.78M | ﹤0.01% | 1624 |
|
|
2016
Q4 | $2.49M | Sell |
38,824
-28,116
| -42% | -$1.73M | ﹤0.01% | 2117 |
|
|
2016
Q3 | $4.33M | Buy |
66,940
+51,990
| +348% | +$2.93M | ﹤0.01% | 1832 |
|
|
2016
Q2 | $828K | Buy |
14,950
+1,300
| +10% | +$65.4K | ﹤0.01% | 3013 |
|
|
2016
Q1 | $570K | Sell |
13,650
-17,451
| -56% | -$810K | ﹤0.01% | 3130 |
|
|
2015
Q4 | $1.95M | Buy |
31,101
+21,101
| +211% | +$1.08M | ﹤0.01% | 2453 |
|
|
2015
Q3 | $407K | Hold |
10,000
| – | – | ﹤0.01% | 3472 |
|
|
2015
Q2 | $515K | Buy |
+10,000
| New | +$531K | ﹤0.01% | 3380 |
|
Other funds holding LKFT
Deutsche Bank's LKFT Position: Q4 2024 in Review
Deutsche Bank sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2024, closing a stake of 375 shares — an estimated $10.8K sold.
Deutsche Bank first reported a position in LKFT in Q2 2015 and held it in 35 quarters. The position peaked at $18.2M in Q1 2022. 81 funds tracked by Wall St. Rank hold LKFT as of Q4 2024.
- Deutsche Bank reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2024 after selling out during the quarter.
- Deutsche Bank sold 375 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2024, an estimated $10.8K.
- Deutsche Bank first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 35 quarters.
- Deutsche Bank's Lakefront Biotherapeutics American Depositary Shares position peaked at $18.2M in Q1 2022.
- 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2024.
Based on Deutsche Bank's 13F filing for Q4 2024, filed 14 Feb 2025.